Abstract S67 Table 1
Eucapnic OSA (n=50)Hypercapnic OSA (n=38)OSA+OHS (n=64)Lone OHS (n=11)
Male36 (72)22 (57.9)29 (45.3)*3 (27.3)*
Age (years)50.0±13.556.1±14.0*56.1±13.8*57.1±17.4
Diabetes mellitus10 (20)17 (48.6)*32 (50.0)*4 (36.4)
Hypertension21 (42)24 (66.7)33 (51.6)5 (45.5)
BMl (kg/m2)44.0±11.446.11±10.053.72±13.9* 48.25±8.9
ESS14.2±6.313.1±5.416.4±5.0*12.7±10.6*
FVC (L)3.0±1.11.9±1.0*1.9±0.9*1.5±0.6*
pH7.41±0.027.39±0.03*7.38±0.03*7.39±0.06
PaO2 (kPa)10.4±1.68.0±1.5*8.0±1.5*7.8±1.3*
PaCO2 (kPa)5.4±0.47.0±0.7* 7.6±1.3* 7.9±1.2*
HCO3 (mmol/l)25.2±1.930.8±3.0*33.0±4.5* 33.5±5.2
Length of stay (days)2.6±2.84.3±2.7*5.1±4.2*6.5±6.0*
1-year mortality0 (0)1 (2.6)2 (3.1)1 (9.1)
  • Data presented as n (%) or mean±SD.

  • OSA, obstructive sleep apnoea; OHS, obesity hypoventilation syndrome; BMI, body mass index; ESS, Epworth sleepiness score; FVC, forced vital capacity.

  • * Significant difference compared to eucapnic OSA group.

  • Significant difference compared to hypercapnic OSA group.

  • Significant difference between hypercapnic OSA group and combined group of OSA+OHS and lone OHS.